Docmode Health Technologies (NSE:DHTL) ROCE %: -11.61% (As of Mar. 2025)


NSE:DHTL Docmode Health Technologies Ltd NSE:DHTL
14 GF Score
Price ₹40.50
! 3 Warning Signs
View Full Analysis

What is Docmode Health Technologies ROCE %?

Docmode Health Technologies NSE:DHTL 14 ROCE % is -11.61% as of Mar. 2025. GuruFocus rates NSE:DHTL with a GF Score™ of 14/100. The stock has 3 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Docmode Health Technologies's annualized ROCE % for the quarter that ended in Mar. 2025 was -11.61%.

Docmode Health Technologies  (NSE:DHTL) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Docmode Health Technologies ROCE % Related Terms

Docmode Health Technologies ROCE % Historical Data

* Premium members only.

The historical data trend for Docmode Health Technologies's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Docmode Health Technologies ROCE % Chart

Docmode Health Technologies Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25
ROCE %
61.76 54.63 54.89 15.34 -0.74

Docmode Health Technologies Semi-Annual Data
Mar21 Mar22 Mar23 Sep23 Mar24 Sep24 Mar25
ROCE % Get a 7-Day Free Trial 0.00 59.89 -14.70 8.13 -11.61
NSE:DHTL
14GF Score
Docmode Health Technologies Ltd NSE:DHTL
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Docmode Health Technologies ROCE % Calculation

Docmode Health Technologies's annualized ROCE % for the fiscal year that ended in Mar. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Mar. 2025 )  (A: Mar. 2024 )(A: Mar. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Mar. 2025 )  (A: Mar. 2024 )(A: Mar. 2025 )
=-0.951/( ( (301.443 - 147.249) + (393.114 - 291.414) )/ 2 )
=-0.951/( (154.194+101.7)/ 2 )
=-0.951/127.947
=-0.74 %

Docmode Health Technologies's ROCE % of for the quarter that ended in Mar. 2025 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2025 )  (Q: Sep. 2024 )(Q: Mar. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2025 )  (Q: Sep. 2024 )(Q: Mar. 2025 )
=-13.45/( ( (261.037 - 131.041) + (393.114 - 291.414) )/ 2 )
=-13.45/( ( 129.996 + 101.7 )/ 2 )
=-13.45/115.848
=-11.61 %

(1) Note: The EBIT data used here is two times the semi-annual (Mar. 2025) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of -11.61% mean?
Docmode Health Technologies (NSE:DHTL) has a ROCE % of -11.61% as of Mar. 2025.
Is Docmode Health Technologies' ROCE % too high?
Docmode Health Technologies' current ROCE % is -11.61%. Overall, Docmode Health Technologies has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Docmode Health Technologies' ROCE % compare to VEEV and BTSG?
Docmode Health Technologies' ROCE % of -11.61% can be compared against companies in the Healthcare Providers & Services industry. The industry median ROCE % is 6.41. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Healthcare Providers & Services company?
The median ROCE % among Healthcare Providers & Services companies is 6.41, based on 648 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median ROCE % is 6.41 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Docmode Health Technologies's current ROCE % is -11.61%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Docmode Health Technologies stock overvalued right now?
Docmode Health Technologies (NSE:DHTL) has a current ROCE % of -11.61%. The current ROCE % is -11.61%. Docmode Health Technologies' overall GF Score™ is 14/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Docmode Health Technologies (NSE:DHTL), the current ROCE % is -11.61% as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Docmode Health Technologies Business Description

Address Chincholi Bunder Road, 201, Kalpataru Plaza, Rambaug Off, Nadiyawala Colony 2, Malad, Mumbai, MH, IND, 400064
Docmode Health Technologies Ltd is engaged in the business of providing comprehensive & interactive learning programs for healthcare professionals through e-Learning measures and providing online CME (continuous medical education) Certification Courses and designing & conducting surveys, quizzes, questionnaires, etc. for collecting data insights related to the healthcare industry Its business segment is engaged in providing vocational training, DocMode is a platform that provides authoritative, comprehensive, and interactive learning programs for Health Professionals - Doctors, Nurses, Allied and Medical Students - across the world. The company has a new segments namely publishing of Medical books, trading of medical books and journals, conducting customised and inhouse events.
14GF Score

Get the complete analysis for NSE:DHTL

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹40.50
Price